Chemoimmune prophylaxis of superficial bladder carcinoma with cyclophosphamide and BCG.
Jaeger
N
N
University Urological Clinic, Bonn, FRG.
Adolphs
H D
HD
Vahlensieck
W
W
D001500:BCG Vaccine / Q000009:adverse effects / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control*; D001743:Urinary Bladder / Q000601:surgery*; D001749:Urinary Bladder Neoplasms / Q000601:surgery*
D001500:BCG Vaccine; D003520:Cyclophosphamide